Main > A1. CORP. INDEX. B-Bm > Bausch & Lomb/P C2

---

This data is not available for free

Bausch & Lomb/P C2's subsections
2001. 11.08.2001. (Executive)
2001. 11.08.2001. (Legal Dispute)
2002. 08.02.2002. (Legal Dispute)
2006. 09.18.2006. Director Global
2006. 09.18.2006. Schering AG
2008. 02.01.2008. (Corp. Acq.)
2008. 11.17.2008. Sr Director Lens
2009. 05.29.2009. Conjunctivitis>BC
2009. 08.03.2009. Cataract Surgery
2010. 03.03.2010. Nicox
2010. 04.03.2010. Vitamin+Mineral
2010. 05.04.2010. Dry Eyes
2010. 06.03.2010. Keratitis
2010. 06.16.2010. CEO &
2010. 06.20.2010. Pres Asia-Pacific
2010. 08.09.2010. Lens Care
2010. 09.02.2010. Corp. VP Human
2010. 09.09.2010. Pres. Pharma.
2010. 09.20.2010. Miotics
2010. 10.29.2010. Pres. LA
2010. 11.04.2010. Appointments
2010. 11.24.2010. Comm. Lead. EMEA
2010. 12.21.2010. Corp. VP Human
2011. 06.30.2011. Pharma Bus IN
2011. 09.23.2011. Pres. Vision Care
2011. 09.26.2011. Inflammation & L
2011. 12.06.2011. Laser
2012. 05.14.2012. Global Pres. Surg
2012. 06.20.2012. Cataract Surgery
2012. 06.28.2012. ONEday
2012. 08.06.2012. TPV
2013. 04.08.2013. Inflammation & B
2013. 04.19.2013. Paragon BioTeck
2013. 05.27. Acq. By:
2013. 07.18. Dry Eye Syndrome (DES)
2017. 04.06. Phacoemulsification
2018. 12.05. USA FDA 510(k) Clear.
2019. 02.22. Post Eye Surgery
2019. 04.02. Post Eye Surgery
2019. 12.11. Astigmatism Cataract+
2020. 06.04. Contact Lenses USA>OK
2020. 08.17. Contact Lenses USA>Lau
2020. 08.18. Contact Lenses AU>OK
2022. 05.24. Canada Approval
2022. 06.02. USA Launch
2022. 06.13. USA Launch
2022. 12.13. FDA 510(k) Clearance
2023. 04.24. USA Launch
Patents
Web-Site
Z - OK

Bausch & Lomb/P C2's products
This section has no products